Seoul: KIMES showcase for Hilterapia® and MLS® laser devices

17 March 2022 - Trade fairs & Congresses -

“In recent years, the South Korean market – explains Giacomo Granozio, ASA Area Manager – has become fond of Hilterapia® which, thanks to its obvious therapeutic results, has won the trust of Korean physiotherapy and rehabilitation professionals, carving out a niche for itself. During the 2022 edition of Kimes, for the first year, the HILT® impulse shared the parterre with MLS®, a much-awaited new entry for the local sector. This means a new era for our brand, which will be able to spread its presence in the country with both therapeutic solutions”.

During the “Korea International Medical & Hospital Equipment Show” (Seoul, 10-13 March 2022), co-protagonists at the Asian Star stand (ASA local distributor) were M6 and MiS, which joined HIRO 3.0 and HIRO TT, expanding and completing the therapeutic offer for the Korean market.

KIMES 2022 - ASA Booth
KIMES 2022 - ASA Booth
KIMES 2022 - Team ASA & Asian Star
KIMES 2022 - Team ASA & Asian Star
KIMES 2022 - Team ASA & Asian Star

Daniel Oh, director of Asian Star, explains:

"This edition of Kimes was held face to face despite Covid-19: unfortunately, there were fewer visitors than in the past due to the recent increase in positive cases; however, since South Korea is a society with a high number of elderly people, the doctors and the public present were very interested in rehabilitation techniques, especially in MLS® and Hilterapia®. I hope that this pandemic will end soon, so that seminars and conferences can be held normally, giving us the opportunity to pick up where we left off. Personally, I expect customers to be very eager to learn more about the use of new medical technologies that best meet patients’ needs and help them recover”.

Granozio feels the same and points out:

“It was a real shame that we were not able to visit the exhibition in person due to international travel restrictions; our partner made a very elegant stand to promote our various therapeutic solutions. However, daily contacts and growing web activities are making our cooperation on site stronger every day, such that we have launched MLS® Laser Therapy on this market, which we expect will bring exciting results, at least as much as Hilterapia®.”

Tutto Schermo
KIMES 2022 - ASA Booth

You might also be interested in ...

See all articles

Dolore alla spalla emiplegica - trattamento laser MLS
Blog - 17/04/2025
MLS® Laser Therapy for hemiplegic shoulder pain: a new opportunity in rehabilitation
One of the most frequent complications after a stroke is hemiplegic shoulder pain (HSP), a problem that affects up to 70% of patients and often hinders the rehabilitation process.
Formacion Laserterapia ASAlaser en LATAM
News - 18/03/2025
ASA expands MLS® Laser Therapy in South America: training, innovation and new business opportunities
ASA continues its expansion in Latin America, strengthening the presence of MLS® Laser Therapy among doctors, physiotherapists and specialists in orthopaedics and rehabilitation. With a series of...
MLS Laser Therapy Workshop @ Melbourne
News - 28/11/2024
Melbourne: Illuminate&Alleviate - MLS® in Action
Two days of analysis and seminars focused on MLS® Laser Therapy with the support of laser therapy authorities.
Press - 20/05/2025
ASA celebrates cultural diversity with a tour of the world's gastronomic cultures
The events organised by the Vicenza-based company on the theme "The value of diversity", chosen as the leitmotif for 2025, continue. On the World Day for Cultural Diversity, personnel were involved...
Press - 28/04/2025
ASA: highly sustainable initiatives
From photovoltaic system to green vehicle fleet, from careful waste management to recycling plastic bottles: the Vicenza-based company focuses on concrete actions to promote the spread of an...
Press - 22/04/2025
The M8 robotic laser in the Námestovo rehabilitation centre
The brand-new rehabilitation centre in Námestovo, in northern Slovakia, is already considered to be one of the most modern facilities in the country.